Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 338,126 | 248,031 | 164,656 | 68,305 | 413,738 |
| Depreciation Amortization | 52,686 | 38,551 | 24,546 | 11,530 | 41,204 |
| Income taxes - deferred | -53,276 | -34,161 | -19,092 | -5,761 | 62,195 |
| Accounts receivable | -34,927 | 53,642 | 84,776 | -92,529 | -245,472 |
| Other Working Capital | 15,578 | 53,847 | 50,960 | -106,009 | -190,669 |
| Other Operating Activity | 434,248 | 194,350 | 84,093 | 177,991 | 507,600 |
| Operating Cash Flow | $752,435 | $554,260 | $389,939 | $53,527 | $588,596 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -87,771 | -261,958 | -218,659 | -171,409 | -199,132 |
| PPE Investments | -333,006 | -215,464 | -135,695 | -64,822 | -156,323 |
| Investing Cash Flow | $-420,777 | $-477,422 | $-354,354 | $-236,231 | $-355,455 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | -1,095 | N/A | -534 | -262 | N/A |
| Debt Repayment | -515,191 | -61,935 | -61,125 | N/A | -2,024 |
| Common Stock Issued | 126,045 | -62,237 | -79,984 | 55,042 | 57,393 |
| Common Stock Repurchased | -267,584 | -175,866 | -64,990 | -63,086 | -195,087 |
| Other Financing Activity | 439,278 | 334,146 | 235,575 | 117,260 | 211,909 |
| Financing Cash Flow | $-218,547 | $34,108 | $28,942 | $108,954 | $72,191 |
| Beginning Cash Position | 535,608 | 535,608 | 535,608 | 535,608 | 230,276 |
| End Cash Position | 648,719 | 646,554 | 600,135 | 461,858 | 535,608 |
| Net Cash Flow | $113,111 | $110,946 | $64,527 | $-73,750 | $305,332 |
| Free Cash Flow | |||||
| Operating Cash Flow | 752,435 | 554,260 | 389,939 | 53,527 | 588,596 |
| Capital Expenditure | -333,006 | -215,464 | -135,695 | -64,822 | -156,323 |
| Free Cash Flow | 419,429 | 338,796 | 254,244 | -11,295 | 432,273 |